Bisphosphonates for Secondary Prevention of Osteoporotic Fractures: A Bayesian Network Meta-Analysis of Randomized Controlled Trials

Table 2

Relative ranking of five bisphosphonates according to SUCRA values.

Drugs	New vertebral fractures	New hip fractures	New nonvertebral nonhip fractures
Placebo	0.997	0.701	0.711
Alendronate	0.146	0.185	0.441
Ibandronate	0.701	0.553	0.779
Risedronate	0.580	0.525	0.238
Zoledronate	0.153	0.431	0.166
Etidronate	0.221	0.609	0.642